You have 9 free searches left this month | for more free features.

City

New Haven (1)

Tokyo (1)

Condition

Advanced or Metastatic Solid Tumor (1)

Colorectal Cancer (1)

Glioblastoma (1)

Non-small Cell Lung Cancer (1)

Pancreatic Ductal Adenocarcinoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

Sponsor

Taiho Pharmaceutical Co., Ltd. (1)

Yale University (1)

Collaborator

Arcus Biosciences, Inc. (1)

National Cancer Institute (NCI) (1)

Intervention

ab122 (2)

ab154 (1)

placebo (1)

tas-115 (1)

tas-116 (1)

tas-120 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

ab122

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer Trial in Tokyo (AB122, TAS-116, TAS-120)

Recruiting

Advanced or Metastatic Solid Tumor
+3 more

AB122
+3 more

Tokyo, Japan

A site selected by Taiho Pharmaceutical Co., Ltd.

Aug 5, 2022

Glioblastoma Trial in New Haven (AB122, AB154, Placebo)

Recruiting

Glioblastoma

AB122
+2 more

New Haven, Connecticut

Yale University

Jul 5, 2022